Colorectal surgeons can apply their knowledge of MSCs to play a significant role in the fight against COVID-19.
Utilizing a rat model of renal ischemia-reperfusion injury, Cleveland Clinic researchers show that mesenchymal stem cell secretions improve recovery of renal function and uncover some aspects of how the secretions produce that beneficial effect.
Cleveland Clinic colorectal surgeon Amy Lightner, MD, a leading translational researcher and clinical trials director, talks about stem cells’ potential to improve IBD management.
Stem cells show potential as disease-modifying and restorative therapy in a range of nervous system disorders, but they’re far from ready for prime time. An expert outlines the reasons why and the road ahead.